Axogen, Inc. (AXGN) Covered Calls
Axogen, Inc. is a leading medical technology company dedicated to the science of peripheral nerve repair and regeneration. The company provides a comprehensive portfolio of surgical solutions designed to help surgeons restore nerve function and quality of life for patients with nerve injuries. Its products include processed nerve allografts, nerve connectors, and protectors that support the body natural healing process across various clinical applications in trauma and surgery.
You can sell covered calls on Axogen, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AXGN (prices last updated Fri 4:16 PM ET):
| Axogen, Inc. (AXGN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 38.50 | +1.13 | 38.20 | 39.80 | 2.7M | - | 1.9 |
| Covered Calls For Axogen, Inc. (AXGN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| May 15 | 40 | 2.40 | 37.40 | 6.4% | 80.6% | |
| Jun 18 | 40 | 3.10 | 36.70 | 8.4% | 48.7% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Axogen, Inc. specializes in the development and commercialization of innovative technologies for peripheral nerve repair. Peripheral nerves are responsible for transmitting signals between the brain, spinal cord, and the rest of the body; when damaged, they can cause loss of sensation and motor function. The company provides a platform of products that offer surgeons an alternative to traditional "nerve grafting" or "autografting," which often involves harvesting a healthy nerve from another part of the patient body.
Core Business and Products
The company flagship product is Avance Nerve Graft, a biologically active processed human nerve allograft used to bridge gaps in injured nerves. This product provides a natural scaffold for nerve fibers to grow across a defect. Other key offerings include the Axoguard Nerve Connector, a surgical conduit for tension-free repair of transected nerves, and the Axoguard Nerve Protector, which wraps around injured nerves to protect them from the surrounding environment and prevent scar tissue attachment. These products are utilized in various surgical specialties, including orthopedics, plastic surgery, and oral and maxillofacial surgery.
Competitive Landscape
- Integra LifeSciences Holdings Corporation offers a range of regenerative technology products and surgical instruments. It competes with the company through its collagen-based nerve repair conduits and wraps used in peripheral nerve reconstruction.
- Stryker Corporation provides a vast array of orthopedic and surgical products. It competes in the soft tissue repair market and offers various surgical solutions that overlap with the company reconstructive clinical applications.
- Baxter International Inc. produces specialty surgical products, including sealants and tissue repair technologies. It competes for market share in the broader surgical theater where advanced wound and tissue management is required.
- Medtronic plc is a global leader in medical technology that provides specialized tools for neurological and spinal surgeries, competing in the high-stakes environment of neuro-restorative surgical procedures.
- Johnson & Johnson competes through its Ethicon and DePuy Synthes subsidiaries, offering surgical sutures, tissue repair products, and orthopedic solutions that are frequently used in trauma and reconstructive cases.
Strategic Outlook and Innovation
The strategic focus for Axogen is centered on making its nerve repair solutions the expected standard of care globally. The company is heavily invested in clinical research to generate robust data supporting the efficacy of its allografts compared to traditional autografts. By expanding its sales force and deepening relationships with specialized surgical centers, the company aims to increase the adoption of its nerve repair platform across a wider variety of traumatic injury and surgical revision cases.
Innovation efforts are directed toward the development of next-generation products that enhance the speed and quality of nerve regeneration. This includes research into bioactive coatings and advanced materials that can further reduce the risk of surgical complications and improve long-term patient outcomes. The company is also exploring digital health tools and education platforms for surgeons to standardize surgical techniques and ensure the best possible results for patients suffering from nerve-related disabilities. This commitment to specialized engineering remains the cornerstone of its market position.
| Top 10 Open Interest For May 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | GLD covered calls | 1. | CMPX covered calls | |
| 2. | NVDA covered calls | 7. | HYG covered calls | 2. | FRMI covered calls | |
| 3. | TLT covered calls | 8. | QQQ covered calls | 3. | AXTI covered calls | |
| 4. | IBIT covered calls | 9. | KWEB covered calls | 4. | STNE covered calls | |
| 5. | SPY covered calls | 10. | EEM covered calls | 5. | CLF covered calls | |
Want more examples? AX Covered Calls | AXON Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
